My CPNP

My CPNP provides quick access to the most important features on cpnp.org.

You will see your important notices, and you will have direct access to your exams and other action items.

Log in now to see your personalized page.

User login

Industry News

McKeon A, Robinson MT, McEvoy KM, et al. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Archives of Neurology. 2012;69(2):230-8. doi:10.1001/archneurol.2011.991.
BACKGROUND: Little information is available about the incidence of stiff-man syndrome (SMS) (the classic form or its variants) or about long-term treatment responses and outcomes. OBJECTIVE: To comprehensively describe the characteristics of a cohort of patients with SMS. DESIGN: Observational study. SETTING: Mayo Clinic, Rochester, Minnesota. PATIENTS: Ninety-nine patients with classic SMS vs variants of the disorder, both glutamic acid decarboxylase 65 kD isoform (GAD65) antibody seropositive and...
Kleiter I, Hellwig K, Berthele A, et al. Failure of natalizumab to prevent relapses in neuromyelitis optica. Archives of Neurology. 2012;69(2):239-45. doi:10.1001/archneurol.2011.216.
OBJECTIVE: To describe first experiences with the integrin inhibitor natalizumab, given to patients with suspected relapsing-remitting multiple sclerosis (MS) who were later diagnosed with aquaporin 4-positive neuromyelitis optica (NMO). DESIGN: Retrospective case series. SETTING: Neurology departments at tertiary referral centers in Germany. PATIENTS: Patients with NMO who tested positive for antibodies to aquaporin 4. INTERVENTION: Treatment with natalizumab. MAIN OUTCOME MEASURES: Relapses and...

CPNP News

Get to Know your Board of Directors for 2014-2015

July 1 is the start of CPNP’s fiscal year and the transition of officers on the Board of Directors. We express a wealth of thanks and gratitude to board members who concluded their board term as of June 30, 2014.

College of Psychiatric and Neurologic Pharmacists (CPNP) 2014 Annual Meeting

Phoenix, Arizona served as host city for the College of Psychiatric and Neurologic Pharmacist’s 17th Annual Meeting held April 27-30. This four-day conference hosted 625 attendees and featured nearly 30 hours of cutting-edge scientific presentations, three industry supported symposium, two product theaters and a display of 169 scientific posters. Deanna Kelly, PharmD, BCPP, Professor, University of Maryland, Baltimore, MD, served as Program Chair of the CPNP Annual Meeting.

The College of Psychiatric and Neurologic Pharmacists (CPNP) Announces Saklad Memorial Award and Research Award Recipients Presented at the 2014 CPNP Annual Meeting

Saklad Memorial Award

CPNP was honored to present the Saklad Memorial Award at the 2014 CPNP Annual Meeting for the seventeenth time. This award celebrates the life and work of the late Judith J. Saklad. Dr. Saklad was a founding member of CPNP and nationally recognized as an innovator of pharmaceutical care to children and adults with serious mental disorders, developmental disabilities and mental retardation. The 2014 recipient is Dr. Cynthia Kirkwood.

College of Psychiatric and Neurologic Pharmacists Releases 2013 Residency Director Survey Results

The College of Psychiatric and Neurologic Pharmacists has released the 2013 Residency Program Director Survey results. Every year, the Resident and New Practitioner Committee asks all Residency Directors with a residency program listed on cpnp.org to complete a brief survey. The purpose of this survey is to gather information which will assist the committee and CPNP in:

If you have any questions, please contact us.